Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
|Drug Name||EGFRBi-armed autologous activated T cells|
EGFRBi-armed autologous activated T cells are autologous T-cells that have been armed with a bispecific antibody that binds EGFR and CD3, potentially enhancing T-cell mediated response to EGFR-expressing cells upon antibody binding (NCI Drug Dictionary).
|DrugClasses||EGFR Antibody 43|
|CAS Registry Number||NA|
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|
|Aldesleukin + EGFRBi-armed autologous activated T cells + Sargramostim||Aldesleukin EGFRBi-armed autologous activated T cells Sargramostim||0||1|
|EGFRBi-armed autologous activated T cells||EGFRBi-armed autologous activated T cells||0||6|